Counsel Health acquired by Oura

Oura agreed on 10 November 2026 to acquire the whole of Counsel Health for $500M–1.5bn in cash, subject to adjustment, with completion expected around the end of the calendar year. Founder and chief executive Muthu Alagappan joins the acquirer as chief clinical artificial intelligence officer with the company’s roughly 70 employees. Counsel Health operates a medical consultation service in which a conversational system gathers the patient’s description of their condition, their records and their history, then passes the exchange to a licensed physician who joins within minutes and can diagnose, prescribe, order tests or refer. Its physicians number around fifty, working on demand, and it charges 29 dollars per consultation or 300 dollars annually, while also supplying health plans, health systems and employers. The two companies had worked together since mid-2026, the consultation service having been built into the acquirer’s application, and more than half of its users there had chosen to share their ring data with the physicians treating them. Continuous measurement changes what a remote consultation can establish. A physician seeing a patient for the first time relies on what that patient recalls, whereas one with access to months of heart rate, temperature and sleep data can identify when a pattern departed from the individual’s own baseline, which is the connection the acquisition is intended to make permanent. The price represents roughly seventeen times the 36 million dollars the company had raised, including a 25 million dollar round led by Andreessen Horowitz and GV in 2025. The acquirer had postponed an intended Nasdaq listing on 29 September, an offering of up to 2.2 billion dollars, citing conditions in the market, and funded this acquisition from its own resources. Its revenue reached 1.75 billion dollars for the year to September 2026, 92% above the preceding year, with adjusted EBITDA of 87 million in the final quarter, figures it described as unaudited.